Language Selector

Main Navigation

Business development 2013

In 2013, the EMS Group, globally active in the business areas High Performance Polymers and Specialty Chemicals and with its companies combined in the EMS-CHEMIE HOLDING AG, increased net sales by 7.4% and net operating income (EBIT) by 15.4% compared to the previous year. These are again new record levels for net sales and net operating income (EBIT).

Consolidated net sales in Swiss Francs increased by 7.4% compared to the previous year to reach CHF 1,885 million (1,755), while the increase in local currencies was 8.7%. In the main business area High Performance Polymers, net sales rose by 10.2%. Planned new business was realised successfully and market positions strengthened worldwide. Growth was recorded for all geographical regions and particularly strongly in Asia (namely in China).

Net operating income (EBIT) rose to CHF 369 million (320) which is 15.4% above previous year. Operational cash flow (EBITDA) increased to CHF 424 million (374) and by 13.4% compared to the previous year. The EBIT margin reached 19.6% (18.2%), the EBITDA margin 22.5% (21.3%). Growth achieved with high-margin specialty products in the main area High Performance Polymers had a positive effect on both result and result margin.

Net financial income amounted to CHF 16 million (3).

Net income closed 18.3% above the previous year at CHF 324 million (274). Earnings per share increased to CHF 13.58 (11.45).

For the business year 2013, EMS plans distribution of an ordinary dividend of CHF 8.50 (7.50) per share and an additional extraordinary dividend of CHF 2.50 (2.50) per share. This means that a total of CHF 11.00 (10.00) per share would be distributed.

For the business year 2014, EMS is expecting the economic situation in the global markets to remain favourable. The transparent US Federal Bank policy and economic recovery in Europe support the trust of consumers and investors worldwide and create a positive mood for consumer spending and investments.

EMS will continue its successful strategy of growth with specialty products in the area of High Performance Polymers. Focus will be on further expanding global market positions and successful realisation of innovations. China will be the strategic center of innovation.

For 2014, EMS expects net sales to close slightly above previous year and net operating income (EBIT) to increase slightly over-proportionately.